Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05835141 · ClinicalTrials.gov registry record
Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 100
- Enrollment target
NCT05835141: Completed study, sponsored by University of Southern California.
NCT05835141 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05835141 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
To determine what proportion of patients have inferior angle recess dimensions that could accommodate the OTX-TIC, and what are risk factors for implant contact with the corneal endothelium.
Primary Outcome
Predict contact between simulated OTX-TIC implant and corneal endothelium imaged using the ANTERION AS-OCT system.
Interventions
- OTHER OCT Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2024-05-31 |
What the finished NCT05835141 record still lists
NCT05835141 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OCT Imaging is the first listed.
NCT05835141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05835141 about?
NCT05835141 is a clinical study titled "Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium". To determine what proportion of patients have inferior angle recess dimensions that could accommodate the OTX-TIC, and what are risk factors for implant contact with the corneal endothelium.
What is the current status of trial NCT05835141?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2023-05-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05835141?
The interventions under investigation include: OCT Imaging (OTHER).
Who is sponsoring clinical trial NCT05835141?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI